Author

E. D. Rodriguez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Scientific Communication & Education· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Drakaki· 1 shared A. R. Alfonso· 1 shared A. Ribas· 1 shared A. T. Hoang· 1 shared A. Y. Patel· 1 shared E. C. McCarthy· 1 shared E. P. Ramly· 1 shared G. K. Diep· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Drakaki

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Evolution of a Plastic Surgery Summer Research Program

P. S. Rabbani, A. R. Alfonso, Z. P. Berman, G. K. Diep, J. Lee, E. P. Ramly, J. R. Diaz Siso, E. D. Rodriguez

This paper describes the development and outcomes of a plastic surgery summer research program for first-year medical students over seven years, showing increased research productivity and residency match in plastic surgery.

bioRxiv · May 16, 2022 · PreprintScientific Communication & Education

Inhibition of the IL-17A axis Protects against Immune-related Adverse Events while Supporting Checkpoint Inhibitor Anti-tumor Efficacy

M. G. Lechner, A. Y. Patel, W. Hugo, T. E. Angell, M. I. Cheng, M. S. Pioso, A. T. Hoang, N. Yakobian, E. C. McCarthy, H.-C. Chen, E. D. Rodriguez, L. Guo, M. Astourian, A. Drakaki, P. Famini, , M. A. Su

This study shows that inhibiting the IL-17A axis reduces immune-related adverse events in checkpoint inhibitor-treated mice without affecting anti-tumor efficacy.

bioRxiv · Jan 19, 2022Immunology